[1] Safety Committee of Japanese Society of Anesthesiologists.A guideline for perioperative smoking cessation[J]. J Anesth,2017, 31(2): 297-303.
[2] Kork F, Neumann T, Spies C. Perioperative management ofpatients with alcohol, tobacco and drug dependency[J].Curr Opin Anaesthesiol, 2010, 23(3): 384-390.
[3] Ward EN, Quaye AN, Wilens TE. Opioid use disorders: peri‐operative management of a special population[J]. AnesthAnalg, 2018, 127(2): 539-547.
[4] 中华医学会麻醉学分会 . (2014 版)中国麻醉学指南与专家共识[M]. 北京: 人民卫生出版社, 2014: 73-75.
[5] Doyle DJ, Goyal A, Garmon EH. American society of anes‐thesiologists classification[M]. Treasure Island (FL): Stat‐Pearls Publishing, 2021: 68-75.
[6] Brown KN, Cascella M. Goldman risk indices[M]. Trea‐sure Island (FL): StatPearls Publishing, 2021: 221-225.
[7] Varon J, Marik PE. Perioperative hypertension management[J]. Vasc Health Risk Manag, 2008, 4(3): 615-627.
[8] Cao D, Chandiramani R, Capodanno D, et al. Non-cardiacsurgery in patients with coronary artery disease: risk evalua‐tion and periprocedural management[J]. Nat Rev Cardiol,2021, 18(1): 37-57.
[9] Pannell LM, Reyes EM, Underwood SR. Cardiac risk as‐sessment before non-cardiac surgery[J]. Eur Heart J Cardio‐vasc Imaging, 2013, 14(4): 316-322.
[10] Crossley GH, Poole JE, Rozner MA, et al. The HeartRhythm Society (HRS)/American Society of Anesthesiolo‐gists (ASA) expert consensus statement on the periopera‐tive management of patients with implantable defibrillators,pacemakers and arrhythmia monitors: facilities and patientmanagement this document was developed as a joint proj‐ect with the American Society of Anesthesiologists (ASA),and in collaboration with the American Heart Association(AHA), and the Society of Thoracic Surgeons (STS) [J].Heart Rhythm, 2011, 8(7): 1114-1154.
[11] Yousefzadeh A, Chung F, Wong DT, et al. Smoking cessa‐tion: the role of the anesthesiologist[J]. Anesth Analg,2016, 122(5): 1311-1320.
[12] Bayable SD, Melesse DY, Lema GF, et al. Perioperativemanagement of patients with asthma during elective sur‐gery: a systematic review[J]. Ann Med Surg (Lond), 2021,70: 102874.
[13] Chandler D, Mosieri C, Kallurkar A, et al. Perioperativestrategies for the reduction of postoperative pulmonarycomplications[J]. Best Pract Res Clin Anaesthesiol, 2020,34(2): 153-166.
[14] Pearce A. Evaluation of the airway and preparation for diffi‐culty[J]. Best Pract Res Clin Anaesthesiol, 2005, 19(4):559-579.
[15] Picker O, Beck C, Pannen B. Liver protection in the periop‐erative setting[J]. Best Pract Res Clin Anaesthesiol, 2008,22(1): 209-224.
[16] Mooney JF, Chow CK, Hillis GS. Perioperative renal func‐tion and surgical outcome[J]. Curr Opin Anaesthesiol, 2014,27(2): 195-200.
[17] Himes CP, Ganesh R, Wight EC, et al. Perioperative evalua‐tion and management of endocrine disorders[J]. Mayo ClinProc, 2020, 95(12): 2760-2774.
[18] Leikin JB. Venous thromboembolism prophylaxis using theCaprini score[J]. Dis Mon, 2019, 65(8): 249-298.
[19] 中华医学会骨科学分会 . 中国骨科大手术静脉血栓栓塞症预防指南[J]. 中华骨科杂志, 2016, 36(2): 65-71.
[20] Sessler DI. Temperature monitoring and perioperative ther‐moregulation[J]. Anesthesiology, 2008, 109(2): 318-338.
[21] 周宗科, 黄泽宇, 杨惠林, 等. 中国骨科手术加速康复围手术期氨甲环酸与抗凝血药应用的专家共识[J]. 中华骨与关节外科杂志, 2019, 12(2): 81-88.
[22] Heikkilä K, Peltonen LM, Salanterä S. Postoperative paindocumentation in a hospital setting: a topical review[J].Scand J Pain, 2016, 11: 77-89.
[23] Momeni M, Crucitti M, De Kock M. Patient-controlled an‐algesia in the management of postoperative pain[J]. Drugs,2006, 66(18): 2321-2337.
[24] Martinez L, Ekman E, Nakhla N. Perioperative Opioidsparing strategies: utility of conventional NSAIDs in adults[J]. Clin Ther, 2019, 41(12): 2612-2628.
[25] Gabriel RA, Swisher MW, Sztain JF, et al. State of the artopioid-sparing strategies for post-operative pain in adultsurgical patients[J]. Expert Opin Pharmacother, 2019, 20(8): 949-961.
[26] Jin Z, Gan TJ, Bergese SD. Prevention and treatment ofpostoperative nausea and vomiting (PONV): a review ofcurrent recommendations and emerging therapies[J]. TherClin Risk Manag, 2020, 16: 1305-1317.